AI-based diagnostics company Neurophet secures ₩6 billion in series A

BioWorld 2019.12.02

Neurophet Inc., a South Korean AI-based brain disease diagnostics company, has secured ₩6 billion (US$5.1 million) in series A funding. 

[BioWorld  Jihyun Kim]